Intended for healthcare professionals


Authors' reply on aspirin for primary prevention

BMJ 2001; 322 doi: (Published 20 January 2001) Cite this as: BMJ 2001;322:171
  1. T W Meade (, director,
  2. P J Brennan, Statistician
  1. MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, London EC1M 6BQ

    EDITOR—By implying disagreements with our study1 which are largely misplaced or non-existent, Ramsay et al may have confused doctors who are deciding about aspirin in the primary prevention of coronary heart disease.2 We pointed out that the British Hypertension Society,3 the hypertension optimal treatment trial,4 and our trial1 all say that aspirin treatment should be started only when blood pressure is satisfactory. Since both aspirin and raised blood pressure are risk factors for …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription